High 15-F2t-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy.

Biomed Res Int · 2015 · PMC4609811 · PMID 26509174

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A reduction of TAC (2.3 mmol/L versus 2.1 mmol/L), 15-F 2t -isoprostane (87.3 pg/mL versus 76.8 pg/mL), and TBARS (90.0 nmol/L versus 60.0 nmol/L) levels after supplementation with antioxidants was observed, although these differences did not reach statistical significance compared with placebo.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.